GlaxoSmithKline stops salmeterol study

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2003年 / 937卷 / 1期

关键词：

Asthma; Salmeterol; Asthma Control; Salmeterol Xinafoate; Asthma Episode;

D O I：

10.2165/00128415-200309370-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[21] Comparative efficacy of combination of fluticasone and salmeterol; fluticasone, salmeterol and montelukast; fluticasone, salmeterol, and levocetirizine in moderate persistent asthma: A study of 120 patients
Gupta, Sandeep
Kansal, Amrit P.
Kishan, Jai
CHEST, 2007, 132 (04) : 512S - 512S
[22] CROSSLANGUAGE STUDY OF VOICING IN INITIAL STOPS
LISKER, L
ABRAMSON, AS
JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA, 1963, 35 (11): : 1889 - &
[23] MRC stops WISDOM HRT study
Reactions Weekly, 2002, 927 (1) : 2 - 2
[24] Misleading data analyses in salmeterol (SMART) study
Lurie, P
Wolfe, SM
LANCET, 2005, 366 (9493): : 1261 - 1262
[25] RESULTS OF PRESCRIPTION EVENT MONITORING STUDY OF SALMETEROL
MANN, RD
BRITISH MEDICAL JOURNAL, 1994, 309 (6960): : 1018 - 1018
[26] GlaxoSmithKline presents a biotech facade
Emma Dorey
Nature Biotechnology, 2001, 19 : 294 - 295
[27] Data analyses in salmeterol (SMART) study questioned
Reactions Weekly, 2005, 1074 (1) : 4 - 4
[28] Safety Study of Salmeterol in Asthma in Adults Reply
Stempel, David A.
Yeakey, Anne M.
Pascoe, Steven J.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (11): : 1098 - 1098
[29] GlaxoSmithKline公司总部
DesignInc
世界建筑导报, 2005, (05) : 13 - 13
[30] GlaxoSmithKline presents a biotech facade
Dorey, E
NATURE BIOTECHNOLOGY, 2001, 19 (04) : 294 - 295

← 1 2 3 4 5 →